Masori Therapeutics

What Masori Therapeutics does

Masori Therapeutics (legal entity: MASORI Therapeutics Corporation) is a private, Henderson, Nevada-based for-profit company founded in 2020 that sells an AI-powered software platform aimed at pharmaceutical and life sciences commercial teams. The core product ecosystem comprises MASORI NBA (an AI-driven Next Best Action engine that analyzes EMR/EHR, payer, and claims data to predict HCP engagement timing and disease progression), MASORI GO (a no-code AI platform that supports mainstream large language models, retrieval-augmented generation, automated data processing, and omnichannel notification workflows), MASORI AI Chatbot (positioned as the first U.S. brand medication chatbot, providing MLR-compliant medication information and reporting an 8-minute average user interaction), and MASORI CRM System (an AI-powered pharmaceutical CRM with predictive analytics and automated HCP outreach). Integrations span Salesforce, HubSpot, Zoho, WhatsApp, SMS, and email. Adjacent offerings include a healthcare programmatic advertising add-on and an emerging research-stage product, MASORI SQUAB, which combines quantum key distribution, blockchain, LoRaWAN, and AWS Braket for secure communications.

The company makes money primarily through enterprise SaaS subscriptions and platform licensing, with quote-based, non-publicly-disclosed pricing sold via a sales-led direct enterprise motion (consultative demos and personalized consultation). Additional revenue mechanics include technology integration services delivered through strategic partners. Distribution is structured around direct enterprise sales to pharmaceutical brands, channel reseller partnerships (notably the 2026 collaboration with Intelligent Protection Management Corp, which exposes MASORI GO to 15,000 web hosting customers via IPM Private Cloud AI), and OEM/embedded licensing of the MASORI GO platform into partner private-cloud stacks.

Customer segmentation is vertical, with pharmaceutical companies and healthcare professionals (HCPs) as primary audiences, patients as a secondary persona, and enterprise technology companies (such as IPM) as a tertiary channel for AI platform deployment. Certifiable compliance includes HIPAA for healthcare data handling and an integrated MLR (Medical, Legal, Regulatory) approval workflow embedded across the product surface. Leadership is centered on founder Dane D. Hallberg as Executive Chairman and CEO, a veteran biopharma executive recognized by CIO Insightful among influential AI leaders of 2025.

Name

Masori Therapeutics

Legal name

MASORI Therapeutics Corporation

Website

https://masori.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

251–500 employees

Short description

Masori Therapeutics is a Henderson, Nevada-based AI software company founded in 2020 that sells a pharmaceutical-focused platform—MASORI NBA, GO, CRM, and AI Chatbot—delivering predictive HCP engagement, no-code AI workflows, and MLR-compliant automation to pharma brands and, via channel partners, to enterprise technology customers.

Ownership category

akta.pro rank

Product category

Pharmaceutical AI Software

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

akta.pro secondary industry

Model Governance, Risk & Compliance (GRC) Platforms (HDAAAKAA)

Keywords

• Pharmaceutical AI software
• HCP engagement platforms
• No-code AI platform
• AI chatbot solutions
• Drug commercialization software

Headquarters

HQ city

Henderson

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. SaaS Platform Subscriptions: MASORI offers AI-powered software platforms (MASORI NBA, CRM, GO, AI Chatbot) as solutions to pharmaceutical companies. The subscription model provides pharmaceutical brands access to AI-driven HCP engagement, predictive analytics, marketing automation, and compliance tools on a recurring subscription basis.
2. Platform Licensing: Licensing of MASORI GO no-code AI platform to enterprise customers including IPM's 15,000 web hosting customers, enabling them to adopt AI capabilities with minimal coding requirements.
3. Technology Integration Services: Strategic collaboration delivering MASORI GO technology solutions to partner customer bases, integrating with partner workflows and tools.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

MASORI Therapeutics develops and sells an integrated suite of AI-powered software platforms purpose-built for pharmaceutical and life sciences companies. Its core products — MASORI NBA (Next Best Action), MASORI GO (no-code AI platform), MASORI AI Chatbot, and MASORI CRM System — enable pharmaceutical brands to analyze EMR/EHR and claims data, predict optimal healthcare professional (HCP) engagement moments, automate MLR-compliant omnichannel outreach, and deploy generative AI workflows for drug commercialization.

Product overview

Masori Therapeutics offers an integrated AI-powered platform specifically designed for pharmaceutical and life sciences companies. The core product ecosystem consists of MASORI NBA (AI-powered Next Best Action for HCP engagement), MASORI GO (no-code AI platform for building and deploying generative AI solutions), MASORI AI Chatbot (first U.S. brand medication chatbot), and MASORI CRM System (AI-powered customer relationship management for pharma). These products work as a unified ecosystem where MASORI CRM serves as the backbone, MASORI NBA provides predictive analytics and HCP targeting insights, MASORI GO enables no-code AI workflow automation, and the AI Chatbot delivers 24/7 compliant patient and HCP engagement. The platform integrates with popular CRMs (HubSpot, Zoho, Salesforce) and supports omnichannel outreach via Email, SMS, WhatsApp, and LinkedIn. Additional offerings include programmatic advertising solutions and research into quantum-secured communications.

Differentiator

Problem solved

Functional benefit

Brands

• MASORI GO: No-code AI platform enabling businesses across industries to build, deploy, and scale AI solutions using drag-and-drop workflows, automated data processing, and real-time analytics.
• MASORI NBA
• MASORI CRM
• MASORI AI Chatbot

Products and services

• MASORI NBA (Next Best Action) AI-powered HCP engagement platform that transforms EMR/EHR, payer, and claims data into actionable insights, enabling pharmaceutical brands to engage healthcare professionals at optimal moments with personalized, MLR-compliant content.
• MASORI GO No-code AI platform enabling businesses to build, deploy, and scale generative AI solutions using drag-and-drop workflows, automated data processing, mainstream LLM and RAG engine support, and real-time analytics.
• MASORI AI Chatbot First U.S. brand medication chatbot providing 24/7 MLR-compliant engagement with HCPs and patients, offering instant responses on medications, safety profiles, and healthcare resources across omnichannel platforms including Facebook and WhatsApp.
• MASORI CRM System AI-powered customer relationship management platform tailored for the pharmaceutical industry that leverages real-time data, predictive analytics, and automated workflows to optimize HCP interactions and salesforce effectiveness.
• MASORI SQUAB (Quantum-Secured Blockchain Communications) Secure communications channel research combining quantum key distribution with blockchain technology and LoRaWAN protocol for enhanced network security against quantum computing threats.

Quantifiable outcome

• 35% sales lift with AI-powered HCP interactions
• +6 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability9 records

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Intelligent Protection Management Corp (IPM)coreTechnology or Integration · 19 May 2026Launched IPM Private Cloud AI offering integrating MASORI GO no-code AI development platform into IPM's private cloud infrastructure. Enables enterprise customers to deploy, manage and scale AI-powered applications while maintaining data control and security. Solution targets process automation, data analysis, customer engagement, and intelligent decision support use cases.
• Intelligent Protection Management Corp (IPM)coreStrategic or Co-development Partner · 1 April 2026Strategic collaboration where MASORI integrates its AI application platform (MASORI GO) within IPM's private cloud infrastructure. IPM becomes a hosting partner and delivers MASORI's technology solutions to its 15,000 web hosting customers, enabling them to adopt AI capabilities with minimal coding requirements. The collaboration aims to help IPM customers enhance operations through AI integration while expanding both companies' market reach in the enterprise technology sector.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/MasoriJapan
• LinkedInlinkedin.com/company/able-star-l-l-c-

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Masori Therapeutics